Facilitatory effect of insulin treatment on hepatocellular carcinoma development in diabetes
Abstract Background To evaluate the effect of insulin treatment on the incidence and/or severity of hepatocellular carcinoma (HCC) in a mouse model of HCC based on diabetes. Methods We recently reported that neonatal streptozotocin (STZ) treatment causes type 1 diabetes and subsequent HCC in ddY, In...
Main Authors: | Hayato Baba, Makoto Kurano, Takeshi Nishida, Hideki Hatta, Ryoji Hokao, Koichi Tsuneyama |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-09-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13104-017-2783-6 |
Similar Items
-
Emerging Links between Cadmium Exposure and Insulin Resistance: Human, Animal, and Cell Study Data
by: Aleksandra Buha, et al.
Published: (2020-08-01) -
Treating Alpelisib-Induced Hyperinsulinemia in Patients with Advanced Breast Cancer – A Real-Life Experience
by: Percik R, et al.
Published: (2023-05-01) -
Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights
by: George Jia, et al.
Published: (2024-01-01) -
Development and prognosis of hepatocellular carcinoma in patients with diabetes
by: Takuma Nakatsuka, et al.
Published: (2023-01-01) -
Exogenous Insulin Antibody Syndrome in Patients with Type 2 Diabetes
by: Han CY, et al.
Published: (2023-06-01)